The association between socioeconomic status and the 90-day risk of cardiovascular events after total hip arthroplasty – registry-based study of 103,286 patients

Figures

• 

  Figure 1. Flowchart of final primary total hip arthroplasty (THA) cohort.

• 

  Figure 2. Demographics. Distribution of sex, age, and Charlson comorbidity index score in the 4 SES markers. Sex: Distribution of females and males given in percentages marked on the x-axis. Age: Green line marks the median age and the white lines marks the quantiles. Age is marked on the x-axis. Charlson comorbidity index score: Distribution of the scores given in percentages marked on the x-axis. n: number of THA. Total n = 103,286.

• 

  Figure 3. Cumulative incidence for any CVD at 90 days after THA for cohabitation, level of education, level of income, and level of liquid assets.

• 

  Figure 4. Cumulative incidence at 90 days for any CVD for patients with a prior history of CVD for cohabitation, level of education, level of income, and level of liquid assets.

• 

  Figure 5. Cumulative incidence at 90 days for any CVD for patients without prior CVD for cohabitation, level of education, level of income, and level of liquid assets.

• 

  Figure 6. Relative risk for cardiovascular disease (CVD), acute myocardial infarction (AMI), venous thromboembolism (VTE), deep-vein thrombosis (DVT), stroke, and pulmonary embolism (PE) at 90 days postoperative THA.

• 

  Figure 7. Relative risk at 90 days for any CVD for patients without a prior history of CVD (left panel), and for patients with a prior history of CVD (right panel).

• 

  Figure 8. Relative risk at 90 days for AMI for patients without a prior history of AMI (left panel) and for patients with a prior history of AMI (right panel).

• 

  Figure 9. Relative risk at 90 days for VTE for patients without a prior history of VTE (left panel) and for patients with a prior history of VTE (right panel).

• 

  Figure 10. Relative risk at 90 days for stroke for patients without a prior history of stroke (left panel) and for patients with a prior history of stroke (right panel).

• 

  Figure 11. Relative risk at 90 days for DVT (left panel) and PE (right panel) for patients without a prior history of DVT and PE.

• 

  Figure 12. Risk difference (RD) at 90 days for cardiovascular disease (CVD) for the 4 markers foror all patients (left panel), for patients without a prior history of CVD (middle panel), and for patients with a prior history of CVD (right panel).